The FDA just approved it.
2006-07-04 14:41:32 · 3 answers · asked by brenopa 3 in Health ➔ Diseases & Conditions ➔ Diabetes
The plan is for Pfizer to release it widely in late July or August. Only those who were in clinical trials would have good experience using it, but I have seen/handled the inhalers. They seem very user-friendly. It will only replace your SHORT ACTING insulin. If you are on long acting insulin (Humulin-N, Novolin-N, Lantus, etc), then you still need to take shots. Long term side effects (especially in the lungs of smokers) are still somewhat of a concern to the FDA, so the drug company has to do more testing in these patients.
2006-07-05 17:02:05 · answer #1 · answered by jdfj 2 · 1⤊ 0⤋
It is still undergoing clinical testing here in Canada.
There was a recent invitation to insulin dependent Diabetics to attend the clinical testing of this new device.
2006-07-05 07:01:54 · answer #2 · answered by Angela B 4 · 0⤊ 0⤋
Not yet. It is approved for research only . Not for use
2006-07-05 02:32:46 · answer #3 · answered by J.SWAMY I ఇ జ స్వామి 7 · 0⤊ 0⤋